MARKET SHARE OF RAZI INSTITUTE ANTISERA IN IRAQ

Trade exchanges between Razi Vaccine and Serum Research
Institute and the Ministry of Health in Iraq were negotiated at a joint meeting
in Baghdad.

Dr. Ali Es-haghi, Director General of Razi institute
announced the news on the registration of Polyvalent Scorpion Antinevom and
Hexavalent Snake Antivenom of Razi Vaccine and Serum Research Institute at the
Iraqi Ministry of Health.

Noting that the institute intends to expand trade exchanges
and exports of medical products of the institute to the Iraqi market, Dr.
Es-haghi, added that according to the report of the Iraqi Ministry of Health on
the high quality and effectiveness of Razi Institute antisera used in Iraqi
hospitals and in line with the high capacity of Razi Institute to enter the
market of biological products in Iraq, in the first stage, two medical products
of the institute, Polyvalent Scorpion Antinevom and Hexavalent Snake Antivenom,
were registered by the Iraqi Food and Drug Administration and entered the Iraqi
market.

http://en.areeo.ac.ir/news/market-share-of-razi-institute-antisera-in-iraq